|Huntington's disease: a clinical review|
P McColgan, SJ Tabrizi
European journal of neurology 25 (1), 24-34, 2018
|C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies|
DJH Moss, M Poulter, J Beck, J Hehir, JM Polke, T Campbell, G Adamson, ...
Neurology 82 (4), 292-299, 2014
|Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review|
N Hasan, P McColgan, P Bentley, RJ Edwards, P Sharma
British journal of clinical pharmacology 74 (2), 230-240, 2012
|Large-scale DCMs for resting-state fMRI|
A Razi, ML Seghier, Y Zhou, P McColgan, P Zeidman, HJ Park, O Sporns, ...
Network Neuroscience 1 (3), 222-241, 2017
|The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders|
T Rittman, BC Ghosh, P McColgan, DP Breen, J Evans, CH Williams-Gray, ...
Journal of Neurology, Neurosurgery & Psychiatry 84 (5), 544-551, 2013
|Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington’s disease|
P McColgan, KK Seunarine, A Razi, JH Cole, S Gregory, A Durr, ...
Brain 138 (11), 3327-3344, 2015
|Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis|
RI Scahill, P Zeun, K Osborne-Crowley, EB Johnson, S Gregory, C Parker, ...
The Lancet Neurology 19 (6), 502-512, 2020
|The genetics of sporadic ruptured and unruptured intracranial aneurysms: a genetic meta-analysis of 8 genes and 13 polymorphisms in approximately 20,000 individuals|
P McColgan, KZ Thant, P Sharma
Journal of neurosurgery 112 (4), 714-721, 2010
|Brain regions showing white matter loss in Huntington’s disease are enriched for synaptic and metabolic genes|
P McColgan, S Gregory, KK Seunarine, A Razi, M Papoutsi, E Johnson, ...
Biological psychiatry 83 (5), 456-465, 2018
|Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects|
P McColgan, P Sharma
International journal of cancer 125 (6), 1473-1478, 2009
|Can neuroimaging predict dementia in Parkinson’s disease?|
JH Lanskey, P McColgan, AE Schrag, J Acosta-Cabronero, G Rees, ...
Brain 141 (9), 2545-2560, 2018
|Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease|
FB Rodrigues, L Byrne, P McColgan, N Robertson, SJ Tabrizi, BR Leavitt, ...
Journal of neurochemistry 139 (1), 22-25, 2016
|Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in Huntington’s disease|
FB Rodrigues, LM Byrne, P McColgan, N Robertson, SJ Tabrizi, ...
PloS one 11 (9), e0163479, 2016
|Addenbrooke's Cognitive Examination‐Revised for mild cognitive impairment in Parkinson's disease|
P McColgan, JR Evans, DP Breen, SL Mason, RA Barker, ...
Movement Disorders 27 (9), 1173-1177, 2012
|Educational interventions in neurology: a comprehensive systematic review|
P McColgan, PP McKeown, C Selai, R Doherty‐Allan, MO McCarron
European Journal of Neurology 20 (7), 1006-1016, 2013
|Stem cell tracking in human trials: a meta-regression|
P McColgan, P Sharma, P Bentley
Stem Cell Reviews and Reports 7 (4), 1031-1040, 2011
|Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington’s disease|
P McColgan, KK Seunarine, S Gregory, A Razi, M Papoutsi, JD Long, ...
JCI insight 2 (8), 2017
|The genetics of abdominal aortic aneurysms: a comprehensive meta-analysis involving eight candidate genes in over 16,700 patients.|
P McColgan, GE Peck, RM Greenhalgh, P Sharma
International surgery 94 (4), 350-358, 2009
|Basal ganglia‐cortical structural connectivity in Huntington's disease|
MJU Novak, KK Seunarine, CR Gibbard, P McColgan, B Draganski, ...
Human brain mapping 36 (5), 1728-1740, 2015
|The human motor cortex microcircuit: insights for neurodegenerative disease|
P McColgan, J Joubert, SJ Tabrizi, G Rees
Nature Reviews Neuroscience 21 (8), 401-415, 2020